Plandai Biotechnology, Inc.: 10-Q filed 2014-05-14
What Plandai Biotechnology, Inc. reported in its quarterly report filed 2014-05-14 (fiscal Q3 2014): 33 published measures, 84 facts as tagged in accession 0001262463-14-000424.
This filing
- Form
- 10-Q (quarterly report)
- Filed
- 2014-05-14
- Fiscal period
- fiscal Q3 2014
- Accession
- 0001262463-14-000424 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All Plandai Biotechnology, Inc. filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-03-31 | 9,771,598 | USD | |
| At 2013-06-30 | 8,835,482 | USD |
Total liabilities
Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-03-31 | 13,204,877 | USD | |
| At 2013-06-30 | 12,319,844 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-03-31 | -3,433,279 | USD | |
| At 2013-06-30 | -3,484,362 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-03-31 | 626,082 | USD | |
| At 2013-06-30 | 498,917 | USD | |
| At 2013-03-31 | 574,760 | USD | |
| At 2012-06-30 | 5,112 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-01-01 to 2014-03-31 | -3,054,877 | USD | 90 |
| 2013-07-01 to 2014-03-31 | -7,096,612 | USD | 274 |
| 2013-01-01 to 2013-03-31 | -1,031,044 | USD | 90 |
| 2012-07-01 to 2013-03-31 | -1,958,106 | USD | 274 |
Operating cash flow
Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-07-01 to 2014-03-31 | -1,832,710 | USD | 274 |
| 2012-07-01 to 2013-03-31 | -1,522,536 | USD | 274 |
Capital expenditure payments
Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-07-01 to 2014-03-31 | 1,111,584 | USD | 274 |
| 2012-07-01 to 2013-03-31 | 1,074,499 | USD | 274 |
Revenue
Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-01-01 to 2014-03-31 | 12,554 | USD | 90 |
| 2013-07-01 to 2014-03-31 | 250,859 | USD | 274 |
| 2013-01-01 to 2013-03-31 | 65,850 | USD | 90 |
| 2012-07-01 to 2013-03-31 | 313,716 | USD | 274 |
Financing cash flow
Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-07-01 to 2014-03-31 | 3,071,459 | USD | 274 |
| 2012-07-01 to 2013-03-31 | 3,702,181 | USD | 274 |
Investing cash flow
Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-07-01 to 2014-03-31 | -1,111,584 | USD | 274 |
| 2012-07-01 to 2013-03-31 | -1,609,997 | USD | 274 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-03-31 | -17,563,674 | USD | |
| At 2013-06-30 | -10,903,813 | USD |
Net property, plant and equipment
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-03-31 | 8,893,686 | USD | |
| At 2013-06-30 | 7,924,910 | USD |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-01-01 to 2014-03-31 | -2,904,119 | USD | 90 |
| 2013-07-01 to 2014-03-31 | -4,635,522 | USD | 274 |
| 2013-01-01 to 2013-03-31 | -957,525 | USD | 90 |
| 2012-07-01 to 2013-03-31 | -1,780,807 | USD | 274 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-03-31 | 635,711 | USD | |
| At 2013-06-30 | 518,994 | USD |
Interest expense
Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-01-01 to 2014-03-31 | 134,754 | USD | 90 |
| 2013-07-01 to 2014-03-31 | 374,654 | USD | 274 |
| 2013-01-01 to 2013-03-31 | 73,519 | USD | 90 |
| 2012-07-01 to 2013-03-31 | 179,952 | USD | 274 |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-03-31 | 557,892 | USD | |
| At 2013-06-30 | 903,740 | USD |
Net current accounts receivable
Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-03-31 | 6,357 | USD | |
| At 2013-06-30 | 13,638 | USD |
Operating expenses
Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-01-01 to 2014-03-31 | 2,775,627 | USD | 90 |
| 2013-07-01 to 2014-03-31 | 4,402,706 | USD | 274 |
| 2013-01-01 to 2013-03-31 | 667,012 | USD | 90 |
| 2012-07-01 to 2013-03-31 | 1,373,685 | USD | 274 |
Net inventory
Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-03-31 | 3,272 | USD | |
| At 2013-06-30 | 6,439 | USD |
Gross profit
Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-01-01 to 2014-03-31 | -128,492 | USD | 90 |
| 2013-07-01 to 2014-03-31 | -232,816 | USD | 274 |
| 2013-01-01 to 2013-03-31 | -290,513 | USD | 90 |
| 2012-07-01 to 2013-03-31 | -407,122 | USD | 274 |
Research and development expense
Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-07-01 to 2014-03-31 | 83,230 | USD | 274 |
| 2012-07-01 to 2013-03-31 | 23,098 | USD | 274 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-03-31 | 128,023,828 | shares | |
| At 2013-06-30 | 106,270,760 | shares |
Additional paid-in capital
Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-03-31 | 15,099,420 | USD | |
| At 2013-06-30 | 7,833,976 | USD |
Total equity including noncontrolling interests
Equity including the portion attributable to noncontrolling interests. It is larger than or equal to parent stockholders equity and is not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-03-31 | -2,140,337 | USD | |
| At 2013-06-30 | -2,628,172 | USD |
Gross property, plant and equipment
Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-03-31 | 9,138,608 | USD |
Accumulated depreciation on property, plant and equipment
Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-03-31 | 244,922 | USD |
Other noncurrent assets
Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-03-31 | 159,582 | USD | |
| At 2013-06-30 | 380,929 | USD |
Accrued current liabilities
Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-03-31 | 22,570 | USD | |
| At 2013-06-30 | 93,184 | USD |
Comprehensive income or loss
Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-01-01 to 2014-03-31 | -2,823,670 | USD | 90 |
| 2013-07-01 to 2014-03-31 | -6,518,183 | USD | 274 |
| 2013-01-01 to 2013-03-31 | -572,170 | USD | 90 |
| 2012-07-01 to 2013-03-31 | -1,236,735 | USD | 274 |
General and administrative expense
General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-01-01 to 2014-03-31 | 113,152 | USD | 90 |
| 2013-07-01 to 2014-03-31 | 102,236 | USD | 274 |
| 2013-01-01 to 2013-03-31 | 180,206 | USD | 90 |
| 2012-07-01 to 2013-03-31 | 445,740 | USD | 274 |
Depreciation expense
Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-01-01 to 2014-03-31 | 43,774 | USD | 90 |
| 2013-07-01 to 2014-03-31 | 142,808 | USD | 274 |
| 2013-01-01 to 2013-03-31 | 40,500 | USD | 90 |
| 2012-07-01 to 2013-03-31 | 87,822 | USD | 274 |
Change in accounts receivable
The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-07-01 to 2014-03-31 | -7,281 | USD | 274 |
| 2012-07-01 to 2013-03-31 | 11,516 | USD | 274 |
Change in inventories
The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-07-01 to 2014-03-31 | -3,167 | USD | 274 |
| 2012-07-01 to 2013-03-31 | 6,742 | USD | 274 |
Inspect the source
- Entity
- Plandai Biotechnology, Inc. / CIK 0001317880
- Captured
- SEC response SHA-256
e24b67d85b1d2e03527e4a75cf3f495a155375a1a0e10302aff7f4632fcf21aa
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001317880.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))